Hofseth BioCare ASA
Hofseth BioCare ASA produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, rest of Europe, Japan, Asia, and the United States. The company offers ProGo, a bioactive peptide for weight management and metabolic health; OmeGo, a salmon oil that provides a full spectrum of fatty acids and omegas; CalGo and NT-II, which are ca… Read more
Hofseth BioCare ASA (HOFBF) - Total Assets
Latest total assets as of December 2025: $394.27 Million USD
Based on the latest financial reports, Hofseth BioCare ASA (HOFBF) holds total assets worth $394.27 Million USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Hofseth BioCare ASA - Total Assets Trend (2010–2025)
This chart illustrates how Hofseth BioCare ASA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Hofseth BioCare ASA - Asset Composition Analysis
Current Asset Composition (December 2025)
Hofseth BioCare ASA's total assets of $394.27 Million consist of 41.0% current assets and 59.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 17.0% |
| Accounts Receivable | $21.52 Million | 5.5% |
| Inventory | $59.83 Million | 15.2% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $36.50 Million | 9.3% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2010–2025)
This chart illustrates how Hofseth BioCare ASA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hofseth BioCare ASA's current assets represent 41.0% of total assets in 2025, an increase from 15.4% in 2010.
- Cash Position: Cash and equivalents constituted 17.0% of total assets in 2025, up from 2.7% in 2010.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 9.0% of total assets, a decrease from 29.0% in 2010.
- Asset Diversification: The largest asset category is inventory at 15.2% of total assets.
Hofseth BioCare ASA Competitors by Total Assets
Key competitors of Hofseth BioCare ASA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
General Mills Inc
NYSE:GIS
|
USA | $32.55 Billion |
|
Maniker F & G Co. Ltd
KQ:195500
|
Korea | ₩123.42 Billion |
|
Xiwang Foodstuffs Co Ltd
SHE:000639
|
China | CN¥6.08 Billion |
|
Nanfang Black Sesame Group Co Ltd
SHE:000716
|
China | CN¥4.57 Billion |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
China | CN¥5.88 Billion |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
China | CN¥40.64 Billion |
|
Xinjiang Chalkis Co Ltd
SHE:000972
|
China | CN¥1.25 Billion |
|
Daehan Flour Mills Co Ltd
KO:001130
|
Korea | ₩1.61 Trillion |
Hofseth BioCare ASA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Hofseth BioCare ASA generates 0.65x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Hofseth BioCare ASA is currently not profitable relative to its asset base.
Hofseth BioCare ASA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.67 | 0.67 | 2.09 |
| Quick Ratio | 0.42 | 0.33 | 1.38 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-79.42 Million | $ -56.36 Million | $ 130.76 Million |
Hofseth BioCare ASA - Advanced Valuation Insights
This section examines the relationship between Hofseth BioCare ASA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 647.46 |
| Latest Market Cap to Assets Ratio | 0.04 |
| Asset Growth Rate (YoY) | 15.5% |
| Total Assets | $394.27 Million |
| Market Capitalization | $14.89 Million USD |
Valuation Analysis
Below Book Valuation: The market values Hofseth BioCare ASA's assets below their book value (0.04 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Hofseth BioCare ASA's assets grew by 15.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Hofseth BioCare ASA (2010–2025)
The table below shows the annual total assets of Hofseth BioCare ASA from 2010 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $394.27 Million | +15.50% |
| 2024-12-31 | $341.37 Million | -12.50% |
| 2023-12-31 | $390.12 Million | -5.09% |
| 2022-12-31 | $411.03 Million | -1.19% |
| 2021-12-31 | $415.97 Million | -9.40% |
| 2020-12-31 | $459.13 Million | +56.69% |
| 2019-12-31 | $293.01 Million | +55.90% |
| 2018-12-31 | $187.94 Million | +2.01% |
| 2017-12-31 | $184.24 Million | +15.62% |
| 2016-12-31 | $159.35 Million | -17.58% |
| 2015-12-31 | $193.35 Million | -11.25% |
| 2014-12-31 | $217.87 Million | +6.25% |
| 2013-12-31 | $205.05 Million | +31.75% |
| 2012-12-31 | $155.64 Million | -1.72% |
| 2011-12-31 | $158.37 Million | +67.48% |
| 2010-12-31 | $94.56 Million | -- |